John D Young Net Worth & Insider Trades

John D Young - Group President, Pfizer Inc

As of December 16, 2021

What is John D Young's Net Worth?

The current estimated net worth of Pfizer Inc's Group President, John D Young, is estimated to be about $26.37M . John D Young owns about 314,325 units of Pfizer Inc common stock. In the last 9 years at Pfizer Inc, John D Young has sold an estimated value of $51.19M worth.

What is John D Young's Past Insider Trading?

John D Young's largest purchase order was 41,700 units , worth over $1.08M on May 11, 2016. John D Young's largest sale order was 150,000 units , worth over $7.51M on November 12, 2021. In total, John D Young has made about 208 transactions over 9 years of their time at Pfizer Inc. John D Young usually trades in July, October and April, with the busiest year in 2018 and 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

John D Young

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John D Young's' Mailing Address?

  • Mailing address is C/o Corporate Secretary 235 East 42nd St. New York NY 10017 NY

Pfizer Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
A. Bourla 2020 $1,650,000 - $4,897,817 $6,782,951 $5,491,800 $1,367,780 $843,222 $21,033,570
A. Bourla 2019 $1,600,000 - $4,290,956 $6,075,290 $3,630,000 $1,726,448 $606,269 $17,928,963
A. Bourla 2018 $1,400,000 - $2,592,079 $3,954,369 $1,533,000 $0 $375,109 $9,854,557
F. D’Amelio 2020 $1,533,750 - $2,406,437 $3,130,596 $2,470,000 $1,318,297 $517,016 $11,376,096
F. D’Amelio 2019 $1,500,000 - $2,582,446 $3,037,649 $1,820,000 $1,612,163 $523,472 $11,075,730
F. D’Amelio 2018 $1,407,917 - $2,013,091 $2,108,995 $1,310,000 $0 $299,826 $7,139,829
M. Dolsten 2020 $1,433,750 - $2,110,585 $2,608,832 $2,600,000 $928,638 $467,819 $10,149,624
M. Dolsten 2019 $1,400,000 - $2,414,725 $2,531,376 $1,820,000 $987,243 $444,701 $9,598,045
M. Dolsten 2018 $1,306,250 - $2,013,091 $2,108,995 $1,326,000 $0 $315,863 $7,070,199
A. Hwang 2020 $1,142,500 - $1,420,129 $2,087,062 $2,387,800 $405,242 $440,714 $7,883,447
J. Young 2020 $1,285,000 - $1,814,734 $2,087,062 $1,800,000 $1,551,403 $450,994 $8,989,193
J. Young 2019 $1,245,000 - $2,247,004 $2,025,093 $1,675,000 $1,325,847 $441,439 $8,959,383
J. Young 2018 $1,206,250 - $2,013,091 $2,108,995 $1,385,000 $0 $408,379 $7,121,715
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm

What are Pfizer Inc's Past Insider Trades?

Pfizer Inc's most recent insider trade came on May 9, 2023 by Scott Gottlieb who bought 2,000 units worth $77K . In the last 20 years, insiders at Pfizer Inc have sold an estimated value of $979.68M and bought an estimated value of $500.3M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Loretta V Cangialosi, Sr. Vice President,  Albert Bourla, Chairman & CEO,  and Rady A Johnson, Executive Vice President .

PFIZER INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...